Daxor Price to Sales Ratio 2010-2011 | DXR

Historical PS ratio values for Daxor (DXR) over the last 10 years. The current P/S ratio for Daxor as of April 26, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Daxor P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-04-26 9.65 28.17
2011-12-31 8.64 $0.34 25.23
2011-09-30 9.93 $0.34 29.18
2011-06-30 9.57 $0.37 26.11
2011-03-31 9.51 $0.37 25.80
2010-12-31 8.58 $0.37 23.03
2010-09-30 8.00 $0.39 20.28
2010-06-30 8.55 $0.38 22.22
2010-03-31 9.50 $0.39 24.52
2009-12-31 10.15 $0.40 25.68
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.046B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.25
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
RadNet (RDNT) United States $3.314B 96.80
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
U.S Physical Therapy (USPH) United States $1.516B 39.30
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00